Stocks · Health care · Pharmaceutical Preparations

uniQure N.V.

QURE Clue Score22
Fiscal year ends December CIK 0001590560 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Walid Abi-Saab
26 Jun 2026
Chief Medical Officer
Sell
1,434
$46.86
$67.20K
Jeannette Potts
15 Jun 2026
Chief Legal Officer
Sell
5,237
$27.67
$144.91K
Madhavan Balachandran
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Rachelle Suzanne Jacques
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Jack Kaye
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Leonard E Post
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Jeremy P. Springhorn
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Kylie O'Keefe
11 Jun 2026
Chief Customer & Strat Officer
Sell
15,936
$27.06
$431.23K
David D. Meek
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Christian Klemt
4 Mar 2026
Chief Financial Officer
Sell
12,000
$9.06
$108.72K
Jeannette Potts
4 Mar 2026
Chief Legal Officer
Sell
3,412
$9.06
$30.91K
Walid Abi-Saab
4 Mar 2026
Chief Medical Officer
Sell
808
$9.06
$7.32K
Matthew C Kapusta
4 Mar 2026
CEO, Managing Director
Sell
14,581
$9.06
$132.10K
Walid Abi-Saab
2 Mar 2026
Chief Medical Officer
Sell
1,660
$9.95
$16.52K
Jeannette Potts
2 Mar 2026
Chief Legal Officer
Sell
8,578
$9.95
$85.35K
Christian Klemt
2 Mar 2026
Chief Financial Officer
Sell
12,532
$9.95
$124.69K
Matthew C Kapusta
2 Mar 2026
CEO, Managing Director
Sell
34,437
$9.95
$342.65K
Christian Klemt
25 Feb 2026
Chief Financial Officer
Sell
6,217
$23.86
$148.34K
Matthew C Kapusta
25 Feb 2026
CEO, Managing Director
Sell
12,378
$23.86
$295.34K

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 34
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 528,340
History held since 31 Jan 2017